Peter Svennilson
CIK 1606074 · last filed 2023-01-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$158.34M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$56.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | 11,203,333 | $1.54 | $17.25M | $72.49M | 36 | 2023-01-17 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 1,547,409 | $58.01 | $89.77M | -$43.47M | 7 | 2022-05-27 |
| ORIC | Director | 4,616,666 | $8.27 | $38.18M | $0 | 3 | 2021-06-17 |
| RVMD | Director | 705,313 | $153.87 | $108.53M | -$84.23M | 6 | 2021-04-28 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | 2,604,528 | $33.99 | $88.53M | -$1.11M | 2 | 2021-02-19 |
| NRIX | 10%+ Owner | 686,274 | $16.95 | $11.63M | $0 | 1 | 2020-07-29 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 3,102,934 | $0.03 | $99.9K | $0 | 2 | 2019-06-20 |
Recent Filings · Page 4 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-13 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +15 | $180 | EDGAR |
| 2019-11-06 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +8,409 | $100.8K | EDGAR |
| 2019-10-24 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +4,387 | $52.4K | EDGAR |
| 2019-10-21 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +84,939 | $982.6K | EDGAR |
| 2019-10-16 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +103,000 | $1.06M | EDGAR |
| 2019-10-11 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +53,172 | $555.3K | EDGAR |
| 2019-08-09 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +224,664 | $3.15M | EDGAR |
| 2019-08-07 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +6,134 | $85.7K | EDGAR |
| 2019-08-05 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +4,382 | $61.2K | EDGAR |
| 2019-07-31 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +28,056 | $383.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.